awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48368354-650E559D-B12B-4BD4-A00B-D14AF97D5E9C
Q48368354-650E559D-B12B-4BD4-A00B-D14AF97D5E9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48368354-650E559D-B12B-4BD4-A00B-D14AF97D5E9C
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
P2860
Q48368354-650E559D-B12B-4BD4-A00B-D14AF97D5E9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48368354-650E559D-B12B-4BD4-A00B-D14AF97D5E9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
642ee69c3ef2c794fff525bb79baf2b2bb240fa0
P2860
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab.